These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 7903288)

  • 1. Nuclear DNA content, proliferating-cell nuclear antigen (PCNA) and p53 immunostaining in predicting progression of laryngeal cancer in situ lesions.
    Munck-Wikland E; Edström S; Jungmark E; Kuylenstierna R; Lindholm J; Auer G
    Int J Cancer; 1994 Jan; 56(1):95-9. PubMed ID: 7903288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immunohistochemically stained markers (p53, PCNA, bcl-2) in dysplastic lesions of the larynx.
    Krecicki T; Jeleń M; Zalesska-Krecicka M; Szkudlarek T; Szajowski K
    Cancer Lett; 1999 Aug; 143(1):23-8. PubMed ID: 10465333
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Markers for dysplasia of the upper aerodigestive tract. Suprabasal expression of PCNA, p53, and CK19 in alcohol-fixed, embedded tissue.
    Coltrera MD; Zarbo RJ; Sakr WA; Gown AM
    Am J Pathol; 1992 Oct; 141(4):817-25. PubMed ID: 1384338
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of topoisomerase IIalpha, Ki-67, proliferating cell nuclear antigen, p53, and argyrophilic nucleolar organizer regions in vulvar squamous lesions.
    Brustmann H; Naudé S
    Gynecol Oncol; 2002 Aug; 86(2):192-9. PubMed ID: 12144828
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunohistochemical analysis of proliferating cell nuclear antigen, p53 protein and nm23 protein, and nuclear DNA content in transitional cell carcinoma of the bladder.
    Shiina H; Igawa M; Nagami H; Yagi H; Urakami S; Yoneda T; Shirakawa H; Ishibe T; Kawanishi M
    Cancer; 1996 Oct; 78(8):1762-74. PubMed ID: 8859190
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical detection of p53 protein in preneoplastic lesions and squamous cell carcinoma of the head and neck.
    Lavieille JP; Brambilla E; Riva-Lavieille C; Reyt E; Charachon R; Brambilla C
    Acta Otolaryngol; 1995 Mar; 115(2):334-9. PubMed ID: 7610836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Laminin-5 as a predictor of invasiveness in cancer in situ lesions of the larynx.
    Nordemar S; Kronenwett U; Auer G; Högmo A; Lindholm J; Edström S; Tryggvasson K; Linder S; Munck-Wikland E
    Anticancer Res; 2001; 21(1B):509-12. PubMed ID: 11299796
    [TBL] [Abstract][Full Text] [Related]  

  • 8. p53 expression in oat and non-oat small cell lung carcinomas: correlations with proliferating cell nuclear antigen.
    Korkolopoulou P; Oates J; Crocker J; Edwards C
    J Clin Pathol; 1993 Dec; 46(12):1093-6. PubMed ID: 7904273
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Proliferating cell nuclear antigen (PCNA) expression and nuclear DNA content in predicting recurrence after radiotherapy of early glottic cancer.
    Munck-Wikland E; Fernberg JO; Kuylenstierna R; Lindholm J; Auer G
    Eur J Cancer B Oral Oncol; 1993 Jan; 29B(1):75-9. PubMed ID: 7910087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
    Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
    Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Retrospective analysis of selected tumor markers (p53, PCNA, Ki67; DNA ploidy) and ultrastructure in patients with larynx carcinomas].
    Golusiñski W; Szmeja Z; Olofsson J; Biczysko W; Krygier-Stojałzowska A; Majewski P
    HNO; 1998 Mar; 46(3):233-40. PubMed ID: 9583028
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p53 immunostaining and image cytometry DNA analysis in precancerous and cancerous squamous epithelial lesions of the larynx.
    Munck-Wikland E; Kuylenstierna R; Lindholm J; Auer G
    Head Neck; 1997 Mar; 19(2):107-15. PubMed ID: 9059867
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Possible prognostic markers in conjunctival dysplasia and squamous cell carcinoma.
    Aoki S; Kubo E; Nakamura S; Tsuzuki A; Tsuzuki S; Takahashi Y; Akagi Y
    Jpn J Ophthalmol; 1998; 42(4):256-61. PubMed ID: 9749864
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A comprehensive analysis of selected diagnostic methods with respect to their usefulness in evaluating the biology of neoplastic cells in patients with laryngeal cancer.
    Golusinski W; Olofsson J; Szmeja Z; Biczysko W; Krygier-Stojałowska A; Kulczyński B
    Eur Arch Otorhinolaryngol; 1999; 256(6):306-11. PubMed ID: 10456281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Proliferating cell nuclear antigen (PCNA) and p53 in epithelial dysplasia and squamous cell carcinoma of oral mucosa--a marker for poor tumor differentiation, increasing nuclear atypia and invasiveness?
    Lan HA; Zain RB; Saitoh M; Muramatsu Y; Shrestha P; Mori M
    Anticancer Res; 1996; 16(5B):3059-65. PubMed ID: 8920767
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrosarcoma versus fibromatoses and cellular nodular fasciitis. A comparative study of their proliferative activity using proliferating cell nuclear antigen, DNA flow cytometry, and p53.
    Oshiro Y; Fukuda T; Tsuneyoshi M
    Am J Surg Pathol; 1994 Jul; 18(7):712-9. PubMed ID: 7517104
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Early progression stage of malignancy of uterine cervical dysplasia as revealed by immunohistochemical demonstration of increased DNA-instability.
    Khaled A; Imamura Y; Noriki S; Fukuda M
    Eur J Histochem; 2000; 44(2):143-56. PubMed ID: 10968362
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of expression of p53, proliferating cell nuclear antigen, and c-erbB-2 in laryngeal carcinoma.
    Micozkadioğlu D; Unal M; Pata YS; Baştürk M; Cinel L
    Med Sci Monit; 2008 Jun; 14(6):CR299-304. PubMed ID: 18509272
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.